Navigation Links
DURECT Corporation Announces Third Quarter 2013 Financial Results and Update of Programs
Date:11/4/2013

leading existing long acting products on the market and incorporates our ORADUR anti-tampering technology. Our licensee, Orient Pharma, is planning to meet with the Taiwan Food and Drug Administration (TFDA) later this year to discuss the Phase 3 program in that market and is developing its plans for further development in the defined Asian and South Pacific countries to which it has rights from us. We retain rights to all other markets in the world, notably including the U.S., Europe and Japan, and has initiated licensing discussions with other companies now that the lead formulation has been selected.
  • Relday™ (Risperidone Program). In January 2013, Zogenix (our licensee) announced positive single-dose pharmacokinetic (PK) results from a Phase 1 clinical trial of Relday. According to Zogenix, adverse events in the Phase 1 trial in patients diagnosed with schizophrenia were generally mild to moderate and consistent with other risperidone products. The Phase 1 clinical trial for Relday was conducted as a single-center, open-label, safety and PK trial of 30 patients with chronic, stable schizophrenia or schizoaffective disorder. Per Zogenix, based on the favorable safety and PK profile demonstrated with the 25 mg and 50 mg once-monthly doses tested in the Phase 1 trial, Zogenix extended the study to include a 100 mg dose of the same formulation. In May 2013, Zogenix announced positive results with the 100 mg arm, demonstrating dose proportionality across the full dose range that would be anticipated to be used in clinical practice. According to Zogenix, the positive results from this study extension positions Zogenix to begin a multi-dose clinical trial, which would provide the required steady-state pharmacokinetic and safety data prior to initiating Phase 3 development studies, subject to Zogenix's ability to secure a development and commercialization partner prior to initiation of the multi-dose trial.
    Relday is a proprietary, lo
    '/>"/>

  • SOURCE DURECT Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. DURECT Corporation Invites You to Join its Third Quarter 2013 Earnings Conference Call
    2. DURECT Announces Changes to its Board of Directors
    3. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
    4. DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
    5. DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference Call
    6. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
    7. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
    8. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
    9. DURECT to Participate in Upcoming Healthcare Conferences
    10. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
    11. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/1/2015)... -- The Middle Eastern MRI systems market is fast growing. ... all domains of medicine like cardiology, neurology and orthopedics. It ... precision and is as safer tool as it does not ... on equipment into Open system, closed system and straight or ... demand as it is preferred over that currently common closed ...
    (Date:6/1/2015)... June 1, 2015 Novel t ... drive growth , says   GBI Research ... (NSCLC) treatment market will be driven primarily by the introduction ... treatment settings, which either replace or combine with generic chemotherapies. ... Non-Small Cell Lung Cancer Market to 2020 - ...
    (Date:6/1/2015)... , June 1, 2015 Symbiotix Biotherapies, ... $2.3 million Phase 2 Small Business Technology Transfer (STTR) ... National Institute of Allergy and Infectious Diseases (NIAID). The ... developing a novel class of molecular therapeutics from ... clinical candidate, Polysaccharide A (PSA), is the first molecule ...
    Breaking Medicine Technology:Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 3New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3Symbiotix Biotherapies Announces $2.3 Million Award from NIH's National Institute of Allergy and Infectious Diseases (NIAID) 2
    ... BabyPing will unveil a new high ... - CES - this week. The new BabyPing high security ... their infant on iPhone, iPad or iPod Touch through cutting edge ... truly reassuring alternative to old-style monitors by using the latest in ...
    ... 2012 /PRNewswire-Asia/ -- The Ministry of Health and Welfare and ... referred from the Health Authority-Abu Dhabi (HAAD) arrived in South ... The Korean government arranged for domestic hospitals to sign ... Dhabi when HAAD Chairman Mohammed Sultan Al Hameli and CEO ...
    Cached Medicine Technology:BabyPing Wi-Fi Baby Monitor for iOS Debuts at CES - the Next Generation of Baby Monitor is Here 2First Patient from Abu Dhabi Arrives in South Korea for Medical Treatment 2
    (Date:6/2/2015)... CA (PRWEB) June 02, 2015 ... scholarship fund set up by current and former students ... a beloved faculty member from 2002 until his death ... keen intelligence, and depth of feeling, as well as ... fairytales. His capacities as an analyst, teacher, and writer ...
    (Date:6/2/2015)... San Diego, CA (PRWEB) June 02, 2015 ... skin from damaging ultraviolet (UV) sun rays”, states Marta Phillips, ... large selection of men’s sun hats and sun accessories that ... sun exposure are not immediately evident. Sometimes sun damage can ... scalp, ears and neck are prime areas for skin cancer ...
    (Date:6/1/2015)... 2015 The National Association of ... as a 2015-2016 inductee into its VIP Woman of ... distinction for leadership in business. NAPW is the nation’s ... than 700,000 members and over 200 operating Local Chapters. ... prestigious award,” said NAPW President Star Jones. “Her knowledge ...
    (Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Marcia Ditmyer as a 2015-2016 ... Year Circle. She is recognized with this prestigious distinction ... and over 200 operating Local Chapters, NAPW is the ... “I’m pleased to honor Marcia with this important distinction,” ...
    (Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Linda Cade as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... recognize Linda with this important honor,” said NAPW President ...
    Breaking Medicine News(10 mins):Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2
    ... Inc. (NYSE: WLP ), the,nation,s largest ... today the expansion of its innovative disease management ... members in its affiliated health,plans suffering from Bipolar ... each year. The Bipolar Condition Care Program will ...
    ... NuVasive, Inc. (Nasdaq: NUVA ), a medical device ... for the spine, announced today that Alex Lukianov, Chairman and ... Annual J.P. Morgan Healthcare Conference at the Westin St. Francis ... at 11:00 a.m. PT.A live Web cast of the presentation ...
    ... will begin the new year in his new role as ... and father of two, brings his experience to one of ... from the Beaumont, TX area. He attended Lamar University ... minor in cultural anthropology. Equal Health has been in business ...
    ... When , Music industry veteran and TV personality Randy ... a second year to help people living with type 2 ... to encourage them to enroll in The Heart of ... is coming to Philadelphia to urge the tens of thousands ...
    ... & Roll Hall of Fame inductees Jackson Browne and ... the nation,s biggest problem: the health of our peopleWASHINGTON, ... company, and The Vineeta Foundation, a health and human ... Obama,s Inauguration, the Health for All Blue Diamond Ball ...
    ... The Center for Sleep and Pulmonary Medicine Opens in Southwest ... the health of patients with a wide variety of sleep ... The Center for Sleep and Pulmonary Medicine in Southwest Florida. ... at 700 2nd Ave. N, Suite 305, Naples, FL 34102 ...
    Cached Medicine News:Health News:WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder 2Health News:WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder 3Health News:NuVasive to Present at 27th Annual J.P. Morgan Healthcare Conference 2Health News:Equal Health Hires Experienced VP Chandler 2Health News:Randy Jackson and the American Heart Association Encourage Philadelphia Residents to 'Get In The K.N.O.W.' About Improving Type 2 Diabetes Management 2Health News:Health for All Blue Diamond Ball Scheduled to Celebrate Obama's Inauguration 2Health News:Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders 2
    ... with its unique thread design is the ... high resistance to pull out, proven delivery, ... application flexibility. This provides the orthopedic surgeon ... to bone. , ,The TwinFix AB anchor ...
    ... The Sutureless Mitek ConTack Labral Anchor ... L/DL-PLA washer used for soft tissue ... washer adjusts to the bony contour ... The anchor uses Radial Osteo Compression ...
    ... system can be used for open or ... on a sterile disposable inserter. The unique ... reproducible insertion of the anchor into bone. ... Design allows for the two pre-threaded sutures ...
    ... The TACIT Threaded Anchor ... used in craniofacial and ... easy, secure tissue reattachment ... suspension. The small size ...
    Medicine Products: